Prognostic Significance of the CD10⁺CD19⁺CD34⁺ B-Progenitor Immunophenotype in Children with Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group

References

• Korsmeyer S. J. Antigen receptor genes as molecular markers of lymphoid neoplasms. J Clin Invest 1987; 79: 1291–1295
   PubMed Web of Science ®Google Scholar
• Nadler L. M., Korsmeyer S. J., Anderson K. C., et al. B‐cell origin of non‐T‐cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre‐B‐cell differentiation. J Clin Invest 1984; 74: 332–340
   PubMed Web of Science ®Google Scholar
• Pui C. H., Behm F. G., Crist W. M. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 343–362
   PubMed Web of Science ®Google Scholar
• Uckun F. M. Regulation of human B‐cell ontogeny. Blood 1990; 76: 1908–1923
   PubMed Web of Science ®Google Scholar
• Champlin R., Gale R. P. Acute lymphoblastic leukemia: recent advances in biology and therapy [see comments]. Blood 1989; 73: 2051–2066
   PubMed Web of Science ®Google Scholar
• Greaves M. F. Differentiation‐linked leukemogenesis in lymphocytes. Science 1986; 234: 697–704
   PubMed Web of Science ®Google Scholar
• Chen J., Alt F. W. Gene rearrangement and B‐cell development. Curr Opin Immunol 1993; 5: 194–200
   PubMed Web of Science ®Google Scholar
• Fanning L. J., Connor A. M., Wu G. E. Development of the immunoglobulin repertoire. Clin Immunol Immunopathol 1996; 79: 1–14
   PubMedGoogle Scholar
• Hentges F. B lymphocyte ontogeny and immunoglobulin production. Clin Exp Immunol 1994; 97(Suppl 1)3–9
   PubMedGoogle Scholar
• Schroeder H. W., Jr., Mortari F., Shiokawa S., et al. Developmental regulation of the human antibody repertoire. Ann N Y Acad Sci 1995; 764: 242–260
   PubMed Web of Science ®Google Scholar
• Crist W., Boyett J., Roper M., et al. Pre‐B‐cell leukemia responds poorly to treatment: a pediatric oncology group study. Blood 1984; 63: 407–414
   PubMed Web of Science ®Google Scholar
• Crist W., Boyett J., Jackson J., et al. Prognostic importance of the pre‐B‐cell immunophenotype and other presenting features in B‐lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1989; 74: 1252–1259
   PubMed Web of Science ®Google Scholar
• Borowilz M. J., Shuster J. J., Civin C. I., et al. Prognostic significance of CD34 expression in childhood B‐precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1990; 8: 1389–1398
   PubMed Web of Science ®Google Scholar
• Civin C. I., Banquerigo M. L., Strauss L. C., et al. Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My‐10‐positive progenitor cells in normal human bone marrow. Exp Hematol. 1987; 15: 10–7
   PubMed Web of Science ®Google Scholar
• Hurwitz C. A., Loken M. R., Graham M. L., et al. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 1988; 72: 299–307
   PubMed Web of Science ®Google Scholar
• Loken M. R., Shah V. O., Dattilio K. L., et al. Flow cytometric analysis of human bone marrow. II. Normal B‐lymphocyte development. Blood 1987; 70: 1316–1324
   PubMed Web of Science ®Google Scholar
• Pontvert Delucq S., Breton Gorius J., Schmitt C., et al. Characterization and functional analysis of adult human bone marrow cell subsets in relation to B‐lymphoid development. Blood 1993; 82: 417–429
   PubMed Web of Science ®Google Scholar
• Ryan D., Kossover S., Mitchell S., et al. Subpopulations of common acute lymphoblastic leukemia antigen‐positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood 1986; 68: 417–125
   PubMed Web of Science ®Google Scholar
• Steinherz P. G., Gaynon P., Miller D. R., et al. Improved disease‐free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen‐a new intensive therapy protocol: a report from the Childrens Cancer Study Group. J Clin Oncol 1986; 4: 744–752
   PubMed Web of Science ®Google Scholar
• Tubergen D., Gilchrist G., O'Brien A., et al. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features. J Clin Oncol 1993; 11: 527–537
   PubMed Web of Science ®Google Scholar
• Gaynon P. S., Steinherz P. G., Bleyer W. A., et al. Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG‐106 by the Childrens Cancer Study Group. Lancet 1988; 2: 921–924
   PubMed Web of Science ®Google Scholar
• Steinherz P. G., Siegel S. E., Bleyer W. A., et al. Lymphomatous presentation of childhood acute lymphoblastic leukemia. Cancer 1991; 68: 751–758
   PubMed Web of Science ®Google Scholar
• Smith M., Arthur D., Camitta B., et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia [see comments]. J Clin Oncol 1996; 14: 18–24
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Muraguchi A., Ledbetter J. A., et al. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 1989; 73: 1000–1015
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Gajl Peczalska K. J., Provisor A. J., et al. Immunophenotype‐karyotype associations in human acute lymphoblastic leukemia. Blood 1989; 73: 271–280
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Ledbetter J. A. Immuno‐biologic differences between normal and leukemic human B‐cell precursors. Proc Natl Acad Sci U S A 1988; 85: 8603–8607
   PubMed Web of Science ®Google Scholar
• Hollander M., Wolfe D. Nonparametric Statistical Methods. John Wiley & Sons, New York 1973; 115–120
   Google Scholar
• Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat. Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170
   PubMedGoogle Scholar
• Peto R., Pike M. C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and examples. Br J Cancer 1977; 35: 1
   PubMed Web of Science ®Google Scholar
• Cox D. R. Regression models and life tables. Royal Stat SocB 1972; 34: 187–220
   Web of Science ®Google Scholar
• Breslow N. Analysis of survival data under the proportional hazards model. Int Stat Rev 1975; 43: 45–58
   Web of Science ®Google Scholar
• Basso G., Rondelli R., Covezzoli A., et al. The role of immunophenotype in acute lymphoblastic leukemia of infant age. Leuk Lymphoma 1994; 15: 51–60
   PubMed Web of Science ®Google Scholar
• Crist W., Pullen J., Boyett J., et al. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study. Blood 1986; 67: 135–140
   PubMed Web of Science ®Google Scholar
• Pieters R., Raspers G. J., van Wering E. R., et al. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia. Leukemia 1993; 7: 392–397
   PubMed Web of Science ®Google Scholar
• Pui C. H., Rivera G. K., Hancock M. L., et al. Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia 1993; 7: 35–40
   PubMed Web of Science ®Google Scholar
• Pui C. H., Hancock M. L., Head D. R., et al. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood, 82: 889–894
   PubMed Web of Science ®Google Scholar
• Ishii E., Okamura J., Tsuchida M., et al. Infant leukemia in Japan: clinical and biological analysis of 48 cases. Medical And Pediatric Oncology 1991; 19: 28–32
   PubMedGoogle Scholar
• Ludwig W. D., Bartram C. R., Harbott J., et al. Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia 1989; 3: 431–439
   PubMed Web of Science ®Google Scholar
• Pui C. H., Raimondi S. C., Murphy S. B., et al. An analysis of leukemic cell chromosomal features in infants. Blood 1987; 69: 1289–1293
   PubMed Web of Science ®Google Scholar
• Vogler L. B., Crist W. M., Bockman D. E., et al. Pre‐B‐Cell leukemia, a new phenotype of childhood lymphoblastic Leukemia. New England Journal Of Medicine, [Overseas Edition] 1978; 298: 872–878
   PubMed Web of Science ®Google Scholar